Organization WH. Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission. 2022. [updated Sep 9, 2019. https://www.who.int/data/gho/data/indicators/indicator-details/GHO/estimated-percentage-of-pregnant-women-living-with-hiv-who-received-antiretrovirals-for-preventing-mother-to-child-transmission(Updated Sep 9, 2019).

Organization WH. Prevention of mother-to-child transmission. Estimates by WHO region. 2021. https://apps.who.int/gho/data/view.main.23500REG.

Organization WH. Global guidance on criteria and processes for validation: elimination of mother-to-child transmission of HIV, syphilis and hepatitis B virus . 2021. https://www.who.int/publications/i/item/9789240039360.

The LH. The path to elimination of vertical transmission of HIV. Lancet HIV. 2022;9(2):e67.

Article  Google Scholar 

Adepoju P. HIV-free generation within reach for Botswana. Lancet HIV. 2022;9(2):e76–7.

Article  CAS  PubMed  Google Scholar 

Organization WH. Global monitoring framework and strategy for the global plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive (EMTCT). 2012. https://apps.who.int/iris/bitstream/handle/10665/75341/9789241504270_eng.pdf?sequence=1.

Organization WH. Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022–2030. 2022. [updated July 18, 2022. https://www.who.int/publications/i/item/9789240053779. (Updated July 18, 2022).

Zangeneh SZ, Wilson EA, Ahluwalia S, Donnell DJ, Chen YQ, Grinsztejn B, Melo MG, Godbole SV, Hosseinipour MC, Taha T, Kumwenda J, McCauley M, Cohen MS, Nielsen-Saines K. Pregnancy rates and clinical outcomes among women living with HIV enrolled in HPTN 052. AIDS Care. 2022;16:1–9. https://doi.org/10.1080/09540121.2022.2141187.

Article  CAS  Google Scholar 

Nielsen-Saines K, Watts DH, Veloso VG, Bryson YJ, Joao EC, Pilotto JH, et al. Three postpartum antiretroviral regimens to prevent intrapartum HIV infection. N Engl J Med. 2012;366(25):2368–79.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Transmission PoToHDPaPoP. Recommendations for the use of antiretroviral drugs during pregnancy and interventions to reduce perinatal HIV transmission in the United States. 2023. [updated Jan 31, 2023. https://clinicalinfo.hiv.gov/en/guidelines/perinatal/whats-new. (Updated Jan 31, 2023).

Simonon A, Lepage P, Karita E, Hitimana DG, Dabis F, Msellati P, et al. An assessment of the timing of mother-to-child transmission of human immunodeficiency virus type 1 by means of polymerase chain reaction. J Acquir Immune Defic Syndr (1988). 1994;7(9):952–7.

CAS  PubMed  Google Scholar 

Van de Perre P, Simonon A, Msellati P, Hitimana DG, Vaira D, Bazubagira A, et al. Postnatal transmission of human immunodeficiency virus type 1 from mother to infant. A prospective cohort study in Kigali, Rwanda. N Engl J Med. 1991;325(9):593–8.

Article  PubMed  Google Scholar 

Dunn DT. A review of statistical methods for estimating the risk of vertical human immunodeficiency virus transmission. Int J Epidemiol. 1998;27(6):1064–7.

Article  CAS  PubMed  Google Scholar 

Bryson YJ, Luzuriaga K, Sullivan JL, Wara DW. Proposed definitions for in utero versus intrapartum transmission of HIV-1. N Engl J Med. 1992;327(17):1246–7.

Article  CAS  PubMed  Google Scholar 

Sibiude J, Le Chenadec J, Mandelbrot L, Hoctin A, Dollfus C, Faye A, et al. Update of perinatal HIV-1 transmission in France: zero transmission for 5482 mothers on continuous ART from conception and with undetectable viral load at delivery. Clin Infect Dis. 2022. This study provides an updated data on perinatal transmission among 14,000 women living with HIV, demonstrated vertical transmission, and can be eliminated in setting of free access to ART, regular viral load monitoring, infant ART prophylaxis, the absence of breastfeeding, and ART initiation before and continued throughout pregnancy. This study also demonstrated that vertical transmission is highly correlated with detectable viremia at delivery, as established by previous studies.

Dickover RE, Garratty EM, Herman SA, Sim MS, Plaeger S, Boyer PJ, et al. Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. Effect of maternal zidovudine treatment on viral load. Jama. 1996;275(8):599–605.

Article  CAS  PubMed  Google Scholar 

Mofenson LM, Lambert JS, Stiehm ER, Bethel J, Meyer WA 3rd, Whitehouse J, et al. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team. N Engl J Med. 1999;341(6):385–93.

Article  CAS  PubMed  Google Scholar 

Goldenberg RL, Mwatha A, Read JS, Adeniyi-Jones S, Sinkala M, Msmanga G, et al. The HPTN 024 study: the efficacy of antibiotics to prevent chorioamnionitis and preterm birth. Am J Obstet Gynecol. 2006;194(3):650–61.

Article  CAS  PubMed  Google Scholar 

Joubert BR, Franceschini N, Mwapasa V, North KE, Meshnick SR. Regulation of CCR5 expression in human placenta: insights from a study of mother-to-child transmission of HIV in Malawi. PLoS One. 2010;5(2):e9212.

Article  PubMed  PubMed Central  Google Scholar 

Marazzi MC, Liotta G, Nielsen-Saines K, Haswell J, Magid NA, Buonomo E, et al. Extended antenatal antiretroviral use correlates with improved infant outcomes throughout the first year of life. AIDS. 2010;24(18):2819–26.

Article  PubMed  Google Scholar 

Papiernik M, Brossard Y, Mulliez N, Roume J, Brechot C, Barin F, et al. Thymic abnormalities in fetuses aborted from human immunodeficiency virus type 1 seropositive women. Pediatrics. 1992;89(2):297–301.

Article  CAS  PubMed  Google Scholar 

Finocchario-Kessler S, Goggin K, Staggs V, Wanyenze RK, Beyeza-Kashesya J, Mindry D, et al. High report of miscarriage among women living with HIV who want to conceive in Uganda. BMC Res Notes. 2018;11(1):753.

Article  PubMed  PubMed Central  Google Scholar 

Yang L, Cambou MC, Segura ER, De Melo MG, Santos BR, Dos Santos Varella IR, et al. Patterns of pregnancy loss among women living with and without HIV in Brazil, 2008–2018. AJOG Glob Rep. 2022;2(4):100121. This study with a large sample size compared miscarriage and stillbirth risks between women living with HIV and without HIV and demonstrated that HIV confers an increased miscarriage risk between 12 and 20 weeks among people living with HIV.

Article  PubMed  PubMed Central  Google Scholar 

Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O’Sullivan MJ, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med. 1994;331(18):1173–80.

Article  CAS  PubMed  Google Scholar 

Dorenbaum A, Cunningham CK, Gelber RD, Culnane M, Mofenson L, Britto P, et al. Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial. JAMA. 2002;288(2):189–98.

Article  CAS  PubMed  Google Scholar 

Flynn PM, Taha TE, Cababasay M, Fowler MG, Mofenson LM, Owor M, et al. Prevention of HIV-1 transmission through breastfeeding: efficacy and safety of maternal antiretroviral therapy versus infant nevirapine prophylaxis for duration of breastfeeding in HIV-1-infected women with high CD4 cell count (IMPAACT PROMISE): a randomized, open-label, clinical trial. J Acquir Immune Defic Syndr. 2018;77(4):383–92.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guay LA, Musoke P, Fleming T, Bagenda D, Allen M, Nakabiito C, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet. 1999;354(9181):795–802.

Article  CAS  PubMed  Google Scholar 

Kourtis AP, Bulterys M, Nesheim SR, Lee FK. Understanding the timing of HIV transmission from mother to infant. JAMA. 2001;285(6):709–12.

Article  CAS  PubMed  Google Scholar 

Wade NA, Birkhead GS, Warren BL, Charbonneau TT, French PT, Wang L, et al. Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus. N Engl J Med. 1998;339(20):1409–14.

Article  CAS  PubMed  Google Scholar 

Group TIPH. The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1–a meta-analysis of 15 prospective cohort studies. N Engl J Med. 1999;340(13):977–87.

Article  Google Scholar 

Kind C, Rudin C, Siegrist CA, Wyler CA, Biedermann K, Lauper U, et al. Prevention of vertical HIV transmission: additive protective effect of elective cesarean section and zidovudine prophylaxis. Swiss Neonatal HIV Study Group Aids. 1998;12(2):205–10.

CAS  Google Scholar 

Collaboration. EMoD. Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomised clinical trial. Lancet. 1999;353(9158):1035–9.

Article  Google Scholar 

HIV TPoATaMMoCLw. Infant feeding for individuals with HIV in the United States. 2023. https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/whats-new.

Fruhauf T, Coleman JS. A Missed Opportunity for U.S. Perinatal human immunodeficiency virus elimination: pre-exposure prophylaxis during pregnancy. Obstet Gynecol. 2017;130(4):703–9.

Article  PubMed  PubMed Central  Google Scholar 

Organization WH. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach – 2nd ed. 2016. https://apps.who.int/iris/bitstream/handle/10665/208825/9789241549684_eng.pdf?sequence=1&isAllowed=y.

Chagomerana MB, Edwards JK, Zalla LC, Carbone NB, Banda GT, Mofolo IA, et al. Timing of HIV testing among pregnant and breastfeeding women and risk of mother-to-child HIV transmission in Malawi: a sampling-based cohort study. J Int AIDS Soc. 2021;24(3):e25687.

Article  PubMed  PubMed Central  Google Scholar 

Wibabara Y, Lukabwe I, Kyamwine I, Kwesiga B, Ario AR, Nabitaka L, et al. The yield of HIV testing during pregnancy and postnatal period, Uganda, 2015–2018: analysis of surveillance data. AIDS Res Ther. 2021;18(1):35.

Article  PubMed  PubMed Central  Google Scholar 

Ishikawa N, Dalal S, Johnson C, Hogan DR, Shimbo T, Shaffer N, et al. Should HIV testing for all pregnant women continue? Cost-effectiveness of universal antenatal testing compared to focused approaches across high to very low HIV prevalence settings. J Int AIDS Soc. 2016;19(1):21212.

Article  PubMed  PubMed Central  Google Scholar 

Rodriguez PJ, Roberts DA, Meisner J, Sharma M, Owiredu MN, Gomez B, et al. Cost-effectiveness of dual maternal HIV and syphilis testing strategies in high and low HIV prevalence countries: a modelling study. Lancet Glob Health. 2021;9(1):e61–71.

Article  CAS  PubMed  Google Scholar 

Yee LM, Goldberger AR, Garcia PM, Miller ES. Sexual partner testing for HIV to eliminate mother-to-child HIV transmission: a needs assessment in an urban hospital community clinic. J Perinatol. 2017;37(1):21–6.

Article  CAS  PubMed  Google Scholar 

Yeganeh N, Kreitchmann R, Leng M, Nielsen-Saines K, Gorbach PM, Klausner JD. Diagnosis and treatment of sexually transmitted infections in male partners of pregnant women in Brazil. Int J STD AIDS. 2021;32(13):1242–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Olakunde BO, Adeyinka DA, Oladele T, Ozigbu CE. HIV testing among male partners of pregnant women in Nigeria: a missing link in the elimination of mother-to-child transmission of HIV. Int J STD AIDS. 2018;29(4):404–9.